Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I haven’t heard anyone say that the ex-parte reexamination brought by Public Pat

Wolf, you are right.

I think the same way. We discussed many times that the reeaxamine just can be to the disadvatage of PTSC yesterday. The opposite way is also possible. IMO, we have with T&T strong patent layers who know their business and the over all patent procedure very well.

For me, the most important question is if we keep the time frame in TX and furthermore the possible influence to the case itself.

Best wishes

S402005

   

 

Share
New Message
Please login to post a reply